3 results match your criteria: "Anhui Provincial Chest Hospital (Anhui Institute of Tuberculosis Control)[Affiliation]"

Background: Linezolid (LZD) is a cornerstone medication in the treatment of drug-resistant tuberculosis (DR-TB). However, it frequently triggers adverse effects such as bone marrow suppression, optic neuropathy, and peripheral neuropathy, all of which can impact treatment outcomes and prognosis. Contezolid (CZD), a novel oxazolidinone antibiotic, exhibits comparable antimicrobial efficacy against Mycobacterium tuberculosis as LZD, but with potentially enhanced safety profiles.

View Article and Find Full Text PDF
Article Synopsis
  • Pulmonary tuberculosis (TB) is a major health issue in China that not only affects physical health but is also linked to mental health, particularly with depression and social support levels among patients.
  • A study in Anhui Province evaluated the relationship between depression, social support, and socio-demographic factors in TB patients, utilizing structured questionnaires to gather data from 237 individuals.
  • Results indicated that over half of the participants experienced depression, with both objective and subjective social support showing significant negative associations with depression, while the use of social support did not have a notable impact.
View Article and Find Full Text PDF

Background: Coronavirus disease 2019 (COVID-19) has spread rapidly in China and other overseas areas, which has aroused widespread concern. The sharp increase in the number of patients has led to great psychological pressure on health care workers. The purpose of this study was to understand their mental health status and needs, so as to provide a scientific basis for alleviating the psychological pressure of health care workers.

View Article and Find Full Text PDF